Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Free Cash Flow Yield on January 27, 2025: -28.29%

Lifecome Biochemistry Co.,Ltd. Free Cash Flow Yield is -28.29% on January 27, 2025, a -24.46% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Lifecome Biochemistry Co.,Ltd. 52-week high Free Cash Flow Yield is -20.34% on March 11, 2024, which is 28.12% above the current Free Cash Flow Yield.
Lifecome Biochemistry Co.,Ltd. 52-week low Free Cash Flow Yield is -37.54% on September 18, 2024, which is -32.67% below the current Free Cash Flow Yield.
Lifecome Biochemistry Co.,Ltd. average Free Cash Flow Yield for the last 52 weeks is -27.94%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years